| FQs | Fluoroquinolones |
| CDC | Centers for Disease Control and Prevention |
| FDA | Food and Drug Administration |
| FQAD | Fluoroquinolone Associated Disability |
| GI | Gastrointestinal |
| CNS | Central Nervous System |
| GABA | γ-aminobutyric acid |
| CPX | Ciprofloxacin |
| NMDA | (N-methyl-D-aspartate) |
| ACh | Acetylcholine |
| DMV | Dorsal Motor Nucleus of the vagus |
| LC | Locus Coeruleus |
| VNS | Vagus Nerve Stimulation |
| CTL | Control |
| AMX | Amoxicillin |
| PSI | Proximal Small Intestine |
| MSI | Middle Small Intestine |
| DSI | Distal Small Intestine |
| LMM | Linear Mixed effects Model |
| EMMs | Estimated Marginal Means |